Genmab A/S

GMAB.CO · Moat type: REGULIERUNG

MoatScore

2/10

Fair Value

n/a

Margin of Safety

n/a

Rating

MEIDEN

Genmab is a Danish biotechnology company that develops therapeutic antibodies and generates revenue from milestone payments, royalties, and direct product sales through licensing partnerships and its own commercial products.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.